全文获取类型
收费全文 | 28856篇 |
免费 | 967篇 |
国内免费 | 173篇 |
专业分类
耳鼻咽喉 | 180篇 |
儿科学 | 464篇 |
妇产科学 | 407篇 |
基础医学 | 954篇 |
口腔科学 | 291篇 |
临床医学 | 4428篇 |
内科学 | 2134篇 |
皮肤病学 | 52篇 |
神经病学 | 1095篇 |
特种医学 | 318篇 |
外国民族医学 | 1篇 |
外科学 | 16342篇 |
综合类 | 1272篇 |
一般理论 | 6篇 |
预防医学 | 481篇 |
眼科学 | 98篇 |
药学 | 1005篇 |
12篇 | |
中国医学 | 76篇 |
肿瘤学 | 380篇 |
出版年
2024年 | 19篇 |
2023年 | 1023篇 |
2022年 | 1268篇 |
2021年 | 1582篇 |
2020年 | 1602篇 |
2019年 | 883篇 |
2018年 | 834篇 |
2017年 | 804篇 |
2016年 | 878篇 |
2015年 | 768篇 |
2014年 | 1703篇 |
2013年 | 1299篇 |
2012年 | 1344篇 |
2011年 | 1271篇 |
2010年 | 1165篇 |
2009年 | 1116篇 |
2008年 | 1000篇 |
2007年 | 1045篇 |
2006年 | 970篇 |
2005年 | 946篇 |
2004年 | 824篇 |
2003年 | 806篇 |
2002年 | 829篇 |
2001年 | 711篇 |
2000年 | 679篇 |
1999年 | 717篇 |
1998年 | 259篇 |
1997年 | 225篇 |
1996年 | 211篇 |
1995年 | 210篇 |
1994年 | 171篇 |
1993年 | 133篇 |
1992年 | 465篇 |
1991年 | 460篇 |
1990年 | 439篇 |
1989年 | 374篇 |
1988年 | 297篇 |
1987年 | 135篇 |
1986年 | 63篇 |
1985年 | 61篇 |
1984年 | 52篇 |
1983年 | 41篇 |
1982年 | 34篇 |
1981年 | 41篇 |
1980年 | 32篇 |
1979年 | 26篇 |
1978年 | 29篇 |
1977年 | 16篇 |
1976年 | 28篇 |
1974年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
61.
62.
63.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):149-158.e4
BackgroundCoronary artery bypass grafting (CABG) improves survival in patients with heart failure and severely reduced left ventricular systolic function (LVEF). Limited data exist regarding adverse cardiovascular event rates after CABG in patients with heart failure with midrange ejection fraction (HFmrEF; LVEF > 40% and < 55%).MethodsWe analyzed data on isolated CABG patients from the Veterans Affairs national database (2010-2019). We stratified patients into control (normal LVEF and no heart failure), HFmrEF, and heart failure with reduced LVEF (HFrEF) groups. We compared all-cause mortality and heart failure hospitalization rates between groups with a Cox model and recurrent events analysis, respectively.ResultsIn 6533 veterans, HFmrEF and HFrEF was present in 1715 (26.3%) and 566 (8.6%) respectively; the control group had 4252 (65.1%) patients. HFrEF patients were more likely to have diabetes mellitus (59%), insulin therapy (36%), and previous myocardial infarction (31%). Anemia was more prevalent in patients with HFrEF (49%) as was a lower serum albumin (mean, 3.6 mg/dL). Compared with the control group, a higher risk of death was observed in the HFmrEF (hazard ratio [HR], 1.3 [1.2-1.5)] and HFrEF (HR, 1.5 [1.2-1.7]) groups. HFmrEF patients had the higher risk of myocardial infarction (subdistribution HR, 1.2 [1-1.6]; P = .04). Risk of heart failure hospitalization was higher in patients with HFmrEF (HR, 4.1 [3.5-4.7]) and patients with HFrEF (HR, 7.2 [6.2-8.5]).ConclusionsHeart failure with midrange ejection fraction negatively affects survival after CABG. These patients also experience higher rates myocardial infarction and heart failure hospitalization. 相似文献
64.
《The journal of pain》2019,20(9):1040-1047
Tolerance to the antinociceptive effect of mu-opioid receptor agonists, such as morphine and fentanyl, greatly limits their effectiveness for long-term use to treat pain. Clinical studies have shown that combination therapy and opioid rotation can be used to enhance opioid-induced antinociception once tolerance has developed. The mechanism and brain regions involved in these processes are unknown. The purpose of this study was to evaluate the contribution of the ventrolateral periaqueductal gray (vlPAG) to antinociceptive tolerance and cross-tolerance between administration and co-administration of morphine and fentanyl. Tolerance was induced by pretreating rats with morphine or fentanyl or low-dose combination of morphine and fentanyl into the vlPAG followed by an assessment of the cross-tolerance to the other opioid. In addition, tolerance to the combined treatment was assessed. Cross-tolerance did not develop between repeated vlPAG microinjections of morphine and fentanyl. Likewise, there was no evidence of cross-tolerance from morphine or fentanyl to the co-administration of morphine and fentanyl. Co-administration did not cause cross-tolerance to fentanyl. Cross-tolerance was only evident to morphine or morphine and fentanyl combined in rats pretreated with co-administration of low doses of morphine and fentanyl. This finding is consistent with the functionally selective signaling that has been reported for antinociception and tolerance after morphine and fentanyl binding to the mu-opioid receptor. This research supports the notion that combination therapy and opioid rotation may be useful clinical practices to decrease opioid tolerance and other side effects.PerspectiveThis preclinical study shows that there is a decrease in cross-tolerance between morphine and fentanyl within the periaqueductal gray, which is a key brain region in opioid antinociception and tolerance. 相似文献
65.
66.
67.
68.
《Geriatric nursing (New York, N.Y.)》2019,40(5):457-462
Little is known about the prevalence of self-neglect and its predictors among community-dwelling older adults living alone in China. The present study was conducted among 181 older adults living alone in Nanjing, China. Self-neglect was assessed using a self-neglect screening scale. Participants’ sociodemographic data, social network, functional ability, cognitive function, and depression level were also collected through a set of questionnaires. The prevalence of self-neglect among this group of older adults was 23.2%, which is comparative to their counterparts in Korea and in the United States. Only depression (β = 0.361, p < 0.001) and monthly income (β = −0.159, p = 0.025) were identified as significant predictors of self-neglect, accounting for 27.1% of the variance. Understanding self-neglect and its predictive factors is essential to provide culturally relevant and tailored interventions to enhance the confidence and self-care abilities of older adults to maintain their health and well-being. 相似文献
69.
《Australian critical care》2022,35(4):408-414
BackgroundClinically significant post-traumatic stress symptoms (PTSS) have been reported in up to a quarter of paediatric intensive care unit (PICU) survivors. Ongoing PTSS negatively impacts children's psychological development and physical recovery. However, few data regarding associations between potentially modifiable PICU treatment factors, such as analgosedatives and invasive procedures, and children's PTSS have been reported.ObjectivesWe sought to investigate the medical treatment factors associated with children's PTSS after PICU discharge.MethodsA prospective longitudinal cohort study was conducted in two Australian tertiary referral PICUs. Children aged 2-16 y admitted to the PICU between June 2008 and January 2011 for >8 h and <28 d were eligible for participation. Biometric and clinical data were obtained from medical records. Parents reported their child's PTSS using the Trauma Symptom Checklist for Young Children at 1, 3, 6, and 12 months after discharge. Logistic regression was used to assess potential associations between medical treatment and PTSS.ResultsA total of 265 children and their parents participated in the study. In the 12-month period following PICU discharge, 24% of children exhibited clinically elevated PTSS. Median risk of death (Paediatric Index of Mortality 2 [PIM2]) score was significantly higher in the PTSS group (0.31 [IQR 0.14–1.09] v 0.67 [IQR 0.20–1.18]; p = 0.014). Intubation and PICU and hospital length of stay were also significantly associated with PTSS at 1 month, as were midazolam, propofol, and morphine. After controlling for gender, reason for admission, and PIM2 score, only midazolam was significantly and independently associated with PTSS and only at 1 month (adjusted odds ration (aOR) 3.63, 95% CI 1.18, 11.12, p = 0.024). No significant relationship was observed between the use of medications and PTSS after 1 month.ConclusionsElevated PTSS were evident in one quarter (24%) of children during the 12 months after PICU discharge. One month after discharge, elevated PTSS were most likely to occur in children who had received midazolam therapy. 相似文献
70.
BackgroundCarbetocin has been found to be superior to oxytocin in terms of need for additional uterotonics and prevention of postpartum haemorrhage at caesarean delivery. However, this is based on combined data from labouring and non-labouring parturients and it remains unclear how effective carbetocin is in the purely elective setting. The aim of this review was to compare carbetocin to oxytocin in elective caesarean delivery.MethodsMedline, Embase, CINAHL, Web of Science, and the Cochrane databases were searched for randomised controlled trials in any language. The primary outcome was need for additional uterotonics. Secondary outcomes were mean blood loss, need for blood transfusion and incidence of postpartum haemorrhage >1000 mL.ResultsNine studies with a total of 1962 patients were included. Trial sequential analysis confirmed that the information size (n=1692) had surpassed that required (n=1166) in order to demonstrate a statistically significant reduction in the use of additional uterotonics. Need for additional uterotonics was reduced by 53% with carbetocin compared to oxytocin (OR 0.47, 95% CI 0.34 to 0.64; P <0.001, I2=63.5). The number needed-to-treat was 11. The risk of bias, data heterogeneity and inconsistency in reporting bleeding outcomes made it difficult to reach definite conclusions about prevention of PPH.ConclusionsCarbetocin is associated with a reduced need for additional uterotonics when compared with oxytocin at elective caesarean delivery. Standardisation of bleeding-related outcomes in studies is necessary to facilitate synthesis of data in future analyses. 相似文献